Likewise, other consequences may begin to happen, including fluctuations in blood sugar levels, with rises in blood sugar levels occurring, especially in individuals with Type 2 diabetes
Common Side Effects (Both Oral and Injectable): Gastrointestinal Issues: These are the most common side effects for all GLP-1 medications: Nausea: Oral semaglutide (Rybelsus): 11-20% of patients Injectable semaglutide (Wegovy): 44% of patients Injectable tirzepatide (Zepbound): 30-37% of patients Why the difference: Lower bioavailability of oral medication means less systemic exposure, potentially resulting in fewer GI side effects
In rodent Achilles tendon transection models: BPC-157 administration led to: Higher tensile strength Faster load-bearing capacity Improved structural continuity These are functional endpoints meaning the tissue wasnt just healing histologically, but mechanically
Key warnings include risk of thyroid C-cell tumors, pancreatitis, gallbladder disease, risk of acute kidney injury with severe gastrointestinal adverse reactions, and potential diabetic retinopathy complications
A Bayesian network meta-analysis of 14 molecules inhibiting UV daylight-induced pigmentation
An interesting information to notice is that the phenolic compound quercetin is also present in a plant Houttuynia cordata Thunb., along with several other antioxidant phytochemicals (Kumar et al
